Sort
11,323 grants matching “glioblastoma”
Mechanistic and Therapeutic Studies of GPR124/RECK/WNT7-Regulated Blood-Brain Barrier Function
$437,495Calvin J Kuo · Stanford University · R01 · FY2025 · NS
Targeting Glioblastoma Stem Cells through Epigenetic Reprogramming
$437,329Xing Fan · University Of Michigan At Ann Arbor · R01 · FY2020 · NS
Regulation of Stem Cell Protein Stability by Novel Ubiquitin Ligases
$437,202Hui Zhang · University Of Nevada Las Vegas · R15 · FY2018 · GM
Novel Regulation of the Activation and Assembly of the Heterimeric Receptor Tyrosine Kinase Complexes for Cell Signaling
$437,152Hong Sun · University Of Nevada Las Vegas · R15 · FY2020 · CA
Fast Targeted Spectroscopic Imaging for Brain Tumor Imaging at 3T and 7T
$437,080Jullie W Pan · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · EB
Connectivity mapping identified novel combination therapy for glioblastoma
$436,999Nicole Shonka · University Of Nebraska Medical Center · R01 · FY2023 · CA
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma
$436,882Hui Mao · Emory University · R01 · FY2020 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$436,798Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2022 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$436,798Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2023 · CA
Brain Tumor Immunotherapy
$436,461Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
$436,461Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Rare Central Nervous System Cancers Initiative
$436,461Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Molecular Pathogenesis of Pediatric High Grade Glioma
$436,414Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2019 · CA
Pharmacological targeting of circadian clock components to treat glioblastoma
$436,300Satchidananda Panda · Salk Institute For Biological Studies · R01 · FY2019 · CA
Noninvasive assessment of tumor malignancy
$436,298Elizabeth Bullitt · Univ Of North Carolina Chapel Hill · R01 · FY2007 · CA
Whole transcriptome analysis for neurobiology
$436,189Alex Ryutov · Epicenter Software · R44 · FY2012 · NS
Cellular Plasticity and equilibrium in GBM Progression
$436,062Atique U. Ahmed · Northwestern University At Chicago · R01 · FY2025 · NS
HTS for Identification of Novel Inhibitors of Pyk2 Activity
$436,028Joseph C Loftus · Mayo Clinic Arizona · R01 · FY2015 · CA
Development of SHP2 inhibitors for targeted anti-cancer therapy
$435,963Zhong-Yin Zhang · Purdue University · R01 · FY2020 · CA
Cellular Plasticity and equilibrium in GBM Progression
$435,784Atique U. Ahmed · Northwestern University At Chicago · R01 · FY2024 · NS
Hydrogen Sulfide as a Radiosensitizer for Glioblastoma
$435,667Lynn Harrison · Louisiana State Univ Hsc Shreveport · R15 · FY2019 · CA
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma
$435,586Markus Schober · New York University School Of Medicine · R01 · FY2025 · CA
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS
$435,490David Bramhill · Endurx Pharmaceuticals, Inc. · R44 · FY2016 · CA
The function of the PRMT5 methylosome in MTAP deleted cancers
$435,438William R Sellers · Broad Institute, Inc. · R01 · FY2020 · CA
Development of Natural Product Leads as Anticancer Therapeutics
$435,393John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA